BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21470160)

  • 41. Statin therapy for coronary heart disease and its effect on stroke.
    Switzer JA; Hess DC
    Curr Atheroscler Rep; 2006 Jul; 8(4):337-42. PubMed ID: 16822401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy.
    McGirt MJ; Perler BA; Brooke BS; Woodworth GF; Coon A; Jain S; Buck D; Roseborough GS; Tamargo RJ; Heller J; Freischlag JA; Williams GM
    J Vasc Surg; 2005 Nov; 42(5):829-36; discussion 836-7. PubMed ID: 16275430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Editorial comment--statins, stroke outcome, and stroke prevention: when should we start treatment?
    Streifler JY
    Stroke; 2004 May; 35(5):1121-3. PubMed ID: 15073391
    [No Abstract]   [Full Text] [Related]  

  • 44. Statins and stroke.
    Rodríguez-Yáñez M; Agulla J; Rodríguez-González R; Sobrino T; Castillo J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):157-66. PubMed ID: 19124419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statins and ischemic stroke.
    Liao JK
    Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiovascular prevention and pitavastatin].
    Kayıkçıoğlu M
    Turk Kardiyol Dern Ars; 2017 Apr; 45(Suppl 3):8-12. PubMed ID: 28952472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.
    Sarti C; Kaarisalo M; Tuomilehto J
    Drugs Aging; 2000 Jul; 17(1):33-51. PubMed ID: 10933514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathogenetic justification of statin use in ischaemic stroke prevention according to inflammatory theory in development of atherosclerosis].
    Kotlęga D; Ciećwież S; Turowska-Kowalska J; Nowacki P
    Neurol Neurochir Pol; 2012; 46(2):176-83. PubMed ID: 22581600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct vascular effects of HMG-CoA reductase inhibitors.
    Laufs U; Liao JK
    Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Werner N; Nickenig G; Laufs U
    Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Konstantara F; Savopoulos C; Hatzitolios AI
    Atherosclerosis; 2015 Nov; 243(1):65-70. PubMed ID: 26355807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.
    Ishikawa H; Wakisaka Y; Matsuo R; Makihara N; Hata J; Kuroda J; Ago T; Kitayama J; Nakane H; Kamouchi M; Kitazono T;
    Cerebrovasc Dis; 2016; 42(5-6):395-403. PubMed ID: 27376661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statins as potential therapeutic agents in neuroinflammatory disorders.
    Stüve O; Youssef S; Steinman L; Zamvil SS
    Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia.
    Oesterle A; Liao JK
    Curr Vasc Pharmacol; 2019; 17(3):222-232. PubMed ID: 30124154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.
    Artom N; Montecucco F; Dallegri F; Pende A
    Eur J Clin Invest; 2014 Nov; 44(11):1122-34. PubMed ID: 25231921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.